Please login to the form below

Not currently logged in
Email:
Password:

NICE

This page shows the latest NICE news and features for those working in and with pharma, biotech and healthcare.

NICE backs Pfizer’s Xeljanz for RA

NICE backs Pfizer’s Xeljanz for RA

NICE backs Pfizer’ s Xeljanz for RA. But UK’s cost-effectiveness watchdog removes two drugs from CDF. ... alone. Mason added: “We are delighted with the final recommendation issued by NICE for tofacitinib citrate.”.

Latest news

More from news
Approximately 324 fully matching, plus 820 partially matching documents found.

Latest Intelligence

  • Macron, Merkel and May: implications of the 2017 elections for the life science industry Macron, Merkel and May: implications of the 2017 elections for the life science industry

    In April 2017, NICE and NHS England introduced affordability measures to manage the uptake of innovative treatments, including a £20m budget impact threshold for all new medicines. ... The ABPI has pursued legal action, arguing that this contravenes the

  • Proving the Strategic Value of Patients Proving the Strategic Value of Patients

    Patient insights aren’t just a ‘nice to have’, they are essential to understand the space where Pharma’s drugs ‘live’.

  • Uniting around a common goal Uniting around a common goal

    Whether in the NHS, a patient group, NICE, a pharmaceutical company, agency or clinical-setting, the one thing that unites nearly all stakeholders in healthcare is they want to ‘make a

  • Engaging the digital healthcare professional Engaging the digital healthcare professional

    NICE has been actively using Twitter to engage healthcare professionals for some time, and its tweet was shared by medics in the UK and overseas. ... It was also shared by a student midwife who tweeted to Pfizer and NICE asking them to work together to

  • Providing brand value through creativity Providing brand value through creativity

    It is always nice to have an emotional hook, but not all brands can do this at the beginning, some need time to carve out a story and a following. ... Creativity isn’t just a pretty picture and a nice headline. As Bill Bernbach once said, “it’s our

More from intelligence
Approximately 11 fully matching, plus 78 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 32 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is part of the Unlimited group (http://www.unlimitedgroup.com), bringing together consultants and discipline experts from across the group and...

Latest intelligence

Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...
So how do you really engage with patients?
The most valuable insights from patient engagement are the most unexpected ones. Simple things, which may seem unimportant to you, may be the key to making patients’ lives easier and...
data
Avoiding data pitfalls in clinical research
Genomics sequencing and sensors will present new challenges...

Infographics